Munder Capital Management’s Charles River Laboratories CRL Stock Holding History

Munder Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$37M	Buy	619,623 +14,419	+2%	+$825K	0.28%	109
2014 Q2	$32.4M	Buy	605,204 +50,649	+9%	+$2.78M	0.23%	135
2014 Q1	$33.5M	Buy	554,555 +9,567	+2%	+$558K	0.24%	124
2013 Q4	$28.9M	Buy	544,988 +60,774	+13%	+$3.05M	0.21%	136
2013 Q3	$22.4M	Sell	484,214 -2,452	-0.5%	-$113K	0.18%	153
2013 Q2	$20M	Buy	+486,666	New	+$20.9M	0.17%	164

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Munder Capital Management's CRL Position: Q3 2014 in Review

Munder Capital Management increased its Charles River Laboratories (CRL) stake by 2.4% in Q3 2014, buying an estimated $825K and bringing the position to 619,623 shares worth $37M. The position accounts for 0.28% of the portfolio, ranked #109.

Munder Capital Management first reported a position in CRL in Q2 2013 and has held it in 6 quarters since. 255 funds tracked by Wall St. Rank hold CRL as of Q3 2014.

Munder Capital Management held 619,623 shares of Charles River Laboratories worth $37M as of Q3 2014.
Munder Capital Management bought 14,419 Charles River Laboratories shares in Q3 2014, an estimated $825K.
Charles River Laboratories made up 0.28% of Munder Capital Management's portfolio in Q3 2014, its #109 holding.
Munder Capital Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 6 quarters since.
255 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.